The Difference of COVID-19 Vaccination Attitude, Preventive Measures and Knowledge of SARS-COV-2 Between Diabetic Patients and Healthy Citizens in China

References

• Tian D, Sun Y, Xu H, Ye Q. The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant. J Med Virol. 2022;94:2376–2383. doi:10.1002/jmv.27643
   PubMed Web of Science ®Google Scholar
• Salzberger B, Buder F, Lampl B. Epidemiology of SARS-CoV-2. Infection. 2021;49:233–239. doi:10.1007/s15010-020-01531-3
   PubMed Web of Science ®Google Scholar
• Li J, Lai S, Gao GF, Shi W. The emergence, genomic diversity and global spread of SARS-CoV-2. Nature. 2021;600:408–418.
   PubMed Web of Science ®Google Scholar
• Kostoff RN, Briggs MB, Porter AL, Spandidos DA, Tsatsakis A. COVID‑19 vaccine safety. Int J Mol Med. 2020;2020(46):1599–1602.
   Google Scholar
• Lai X, Zhu H, Wang J. Public perceptions and acceptance of COVID-19 booster vaccination in china: a cross-sectional study. Vaccines. 2021;9(12):1461. doi:10.3390/vaccines9121461
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
   PubMed Web of Science ®Google Scholar
• Ejaz H, Alsrhani A, Zafar A. COVID-19 and comorbidities: deleterious impact on infected patients. J Infect Public Health. 2020;13(12):1833–1839. doi:10.1016/j.jiph.2020.07.014
   PubMed Web of Science ®Google Scholar
• Wu J, Zhang J, Sun X. Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 (COVID-19) infection. Diabetes Obes Metab. 2020;22(10):1907–1914. doi:10.1111/dom.14105
   PubMed Web of Science ®Google Scholar
• Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239–1242. doi:10.1001/jama.2020.2648
   PubMed Web of Science ®Google Scholar
• Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020;395:1225–1228. doi:10.1016/S0140-6736(20)30627-9
   PubMed Web of Science ®Google Scholar
• Mehta P, McAuley DF, Brown A, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034. doi:10.1016/S0140-6736(20)30628-0
   PubMed Web of Science ®Google Scholar
• Maddaloni E, Buzzetti R. Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics. Diabetes Metab Res Rev. 2020;36(7):e33213321. doi:10.1002/dmrr.3321
   PubMed Web of Science ®Google Scholar
• Zhou Y, Chi J, Lv W, Wang Y. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19). Diabetes Metab Res Rev. 2021;37:e3377. doi:10.1002/dmrr.3377
   PubMed Web of Science ®Google Scholar
• Hamer M, Gale CR, Batty GD. Diabetes, glycaemic control, and risk of COVID-19 hospitalisation: population-based, prospective cohort study. Metabolism. 2020;112:154344. doi:10.1016/j.metabol.2020.154344
   PubMed Web of Science ®Google Scholar
• McGurnaghan SJ, Weir A. Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland. Lancet. 2021;9:82–93. doi:10.1016/S2213-8587(20)30405-8
   Web of Science ®Google Scholar
• Ali H, Alterki A, Sindhu S. Robust antibody levels in both diabetic and non-diabetic individuals after BNT162b2 mRNA COVID-19 vaccination. Front Immunol. 2021;12:752233. doi:10.3389/fimmu.2021.752233
   PubMed Web of Science ®Google Scholar
• Soetedjo NNM, Iryaningrum MR, Lawrensia S, Permana H. Antibody response following SARS-CoV-2 vaccination among patients with type 2 diabetes mellitus: a systematic review. Diabetes Metab Syndr. 2022;16:102406. doi:10.1016/j.dsx.2022.102406
   PubMed Web of Science ®Google Scholar
• Abdelhafiz AS, Mohammed Z, Ibrahim ME. Knowledge, perceptions, and attitude of Egyptians towards the novel coronavirus disease (COVID-19). J Community Health. 2020;45:881–890. doi:10.1007/s10900-020-00827-7
   PubMed Web of Science ®Google Scholar
• Yeh YC, Chen IH, Ahorsu DK. Measurement invariance of the drivers of COVID-19 vaccination acceptance scale: comparison between Taiwanese and Mainland Chinese-speaking populations. Vaccines. 2021;9:297. doi:10.3390/vaccines9030297
   PubMed Web of Science ®Google Scholar
• Jamaati H, Hashemian SM, Farzanegan B. No clinical benefit of high dose corticosteroid administration in patients with COVID-19: a preliminary report of a randomized clinical trial. Eur J Pharmacol. 2021;897:173947. doi:10.1016/j.ejphar.2021.173947
   PubMed Web of Science ®Google Scholar
• Sterne JAC, Murthy S, Diaz JV; Group, W. H. O. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA. 2020;324(13):1330–1341. doi:10.1001/jama.2020.17023
   PubMed Web of Science ®Google Scholar
• Powers AC, Aronoff DM, Eckel RH. COVID-19 vaccine prioritisation for type 1 and type 2 diabetes. Lancet. 2021;9:140–141. doi:10.1016/S2213-8587(21)00017-6
   Web of Science ®Google Scholar
• Wang J, Jing R, Lai X. Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines. 2020;8(3):482. doi:10.3390/vaccines8030482
   PubMed Web of Science ®Google Scholar
• Lin Y, Hu Z, Zhao Q. Understanding COVID-19 vaccine demand and hesitancy: a nationwide online survey in China. PLoS Negl Trop Dis. 2020;14(12):e0008961. doi:10.1371/journal.pntd.0008961
   PubMed Web of Science ®Google Scholar
• Wang Y, Duan L. COVID-19 vaccine hesitancy and associated factors among diabetes patients: a cross-sectional survey in Changzhi, Shanxi, China. Vaccines. 2022;10:129.
   Web of Science ®Google Scholar
• Brug J, Aro AR, Richardus JH. Risk perceptions and behaviour: towards pandemic control of emerging infectious diseases: international research on risk perception in the control of emerging infectious diseases. Int J Behav Med. 2009;16:3–6. doi:10.1007/s12529-008-9000-x
   PubMed Web of Science ®Google Scholar
• Brug J, Oenema A, Ferreira I. Theory, evidence and Intervention Mapping to improve behavior nutrition and physical activity interventions. Int J Behav Nutr Phys Act. 2005;2:2. doi:10.1186/1479-5868-2-2
   PubMedGoogle Scholar
• Dong C, Liang Q, Ji T. Determinants of vaccine acceptance against COVID-19 in China: perspectives on knowledge and DrVac-COVID19S scale. Int J Environ Res Public Health. 2021;18(21):11192. doi:10.3390/ijerph182111192
   PubMed Web of Science ®Google Scholar